Investor Relations

Tool Kit

Print PagePrint Page
E-mail PageE-mail Page
RSS FeedsRSS Feeds
E-mail AlertsE-mail Alerts

Company Overview

Ampliphi Biosciences Corp is a biotechnology company committed to the development and commercialization of innovative therapies for the prevention and treatment of diseases with significant unmet medical need. Ampliphi Biosciences is based in Seattle, Washington and has been public since May 1994 and its stock trades on the FINRA OTC Bulletin Board under the ticker symbol APHB.PK.

AmpliPhi in the News

New technique will speed up DNA extraction

Anna spent 16 weeks in quarantine to overcome a mutant form of TB: The common diseases mutating into killers
June 21, 2011 – MailOnline

Revived Interest in Bacteriophages
April 26, 2011 -- Current Biology, Volume 21, Issue 8, R267-R270

Recent News

More News >>
 
11/17/11AmpliPhi Biosciences Announces First Closing of $2.7mPrinter Friendly Version
11/08/11AmpliPhi Biosciences appoints Philip J. Young as President & CEOPrinter Friendly Version
09/06/11AmpliPhi Biosciences to Present at Rodman & Renshaw Annual Global Investment Conference in New YorkPrinter Friendly Version
07/14/11Scientists Explore Alternative to AntibioticsPrinter Friendly Version

Upcoming Events

More Events >>
There are currently no events scheduled.

Featured Report

Download Documentation 2008 10-K

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.
APHB (Common Stock)
$0.21 0.00 (0.00%) 3,800
05/18/12 1:22 p.m. ET
Receive E-mail AlertsE-mail Alert Icon
Sign up to receive e-mail alerts whenever Ampliphi Biosciences Corp posts new information to the site. Just enter your e-mail address and click Submit.